[144] Ares Management Corporation SEC Filing

Rhea-AI Filing Summary

Ares Management Corporation (ARES) filing a Form 144 notifies the proposed sale of 112,522 common shares through Morgan Stanley Smith Barney with an aggregate market value of $20,374,358.54. The shares were acquired as founders shares on 05/01/2014. The filing lists recent Rule 10b5-1 sales by TJ CAPITAL INVESTORS LLC totaling 266,743 shares sold on 08/20–08/22/2025 with gross proceeds of $47,415,617.07. The filing affirms the seller does not possess undisclosed material adverse information and references compliance with Rule 10b5-1 trading plans where indicated.

Positive

• Transparent disclosure of proposed sale quantity, broker, and aggregate market value
• Documentation of prior 10b5-1 sales with dates and gross proceeds, improving traceability
• Origin of shares specified (founders shares acquired 05/01/2014), which clarifies holding history

Negative

• Substantial insider liquidity in the form of recent 10b5-1 sales totaling 266,743 shares and proposed additional sale of 112,522
• Material proceeds disclosed (combined recent gross proceeds of $47,415,617.07 plus proposed ~$20.37M) indicating notable insider cashing-out activity

Insights

Securities Analyst

TL;DR: Insider-related sales disclosed; proposed sale is a continuation of recent 10b5-1 activity and is transparent.

The filing shows a planned one-time notice to sell 112,522 founder shares with a market value of about $20.4 million, executed via a broker. The filing also documents three recent 10b5-1 plan sales totaling 266,743 shares and roughly $47.4 million in proceeds across three days. For investors, these disclosures provide clear traceability of insider liquidity events and current share dispositions without introducing any additional company operational information.

Compliance / Corporate Governance Expert

TL;DR: Form 144 appears procedurally complete and cites Rule 10b5-1 usage; signature and representation language included.

The form documents the origin of the shares as founder shares (acquired 05/01/2014) and specifies the broker and proposed sale date (08/25/2025). It includes the required seller representation that no undisclosed material adverse information exists and references the date of plan adoption/instruction fields for 10b5-1 reliance. These elements align with regulatory expectations for disclosure of proposed insider sales.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	112522	20374358.54	215934693	08/25/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/01/2014	Founders Shares	Issuer			112522	05/01/2014	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for TJ CAPITAL INVESTORS LLC 1800 Avenue of the Stars, Suite 1400 Los Angeles CA 90067	Common	08/22/2025	105394	19144535.54
10b5-1 Sales for TJ CAPITAL INVESTORS LLC 1800 Avenue of the Stars, Suite 1400 Los Angeles CA 90067	Common	08/21/2025	63378	11293281.46
10b5-1 Sales for TJ CAPITAL INVESTORS LLC 1800 Avenue of the Stars, Suite 1400 Los Angeles CA 90067	Common	08/20/2025	97971	17477801.07

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What quantity of ARES shares is proposed for sale in this Form 144?

The filing proposes sale of 112,522 common shares through Morgan Stanley Smith Barney.

What is the aggregate market value of the proposed sale for ARES?

The aggregate market value is reported as $20,374,358.54 for the 112,522 shares.

Were there recent insider sales by related parties before this filing?

Yes. The filing lists three 10b5-1 sales by TJ CAPITAL INVESTORS LLC on 08/20/2025, 08/21/2025, and 08/22/2025 totaling 266,743 shares with gross proceeds of $47,415,617.07.

How were the shares being sold originally acquired?

The securities to be sold are identified as founders shares acquired on 05/01/2014 from the issuer.

Does the filer assert they possess any undisclosed material information about ARES?

No. By signing the notice the seller represents that they do not know any material adverse information about the issuer that has not been publicly disclosed.